Patients who were receiving abacavir at study entry had elevated baseline levels of some inflammatory biomarkers. During the course of the study, current abacavir use was associated with higher ...

The company has also announced the receipt of tentative approval from the US regulator under the US President's Emergency Plan for AIDS Relief (PEPFAR) for its Abacavir, Dolutegravir and ...